Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,526 | 515 | 97.2% |
| Travel and Lodging | $261.87 | 2 | 2.7% |
| Education | $10.90 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,583 | 130 | $0 (2024) |
| PFIZER INC. | $1,480 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,142 | 59 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $717.16 | 18 | $0 (2023) |
| Lilly USA, LLC | $622.20 | 55 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $435.31 | 15 | $0 (2023) |
| ABBVIE INC. | $351.56 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $333.25 | 20 | $0 (2022) |
| Amgen Inc. | $327.30 | 19 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $284.32 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $321.15 | 15 | Novo Nordisk Inc ($68.35) |
| 2023 | $740.58 | 38 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($112.72) |
| 2022 | $1,395 | 88 | Novo Nordisk Inc ($327.73) |
| 2021 | $1,354 | 53 | Novo Nordisk Inc ($338.15) |
| 2020 | $431.37 | 31 | Novo Nordisk Inc ($127.10) |
| 2019 | $1,558 | 111 | Novo Nordisk Inc ($433.67) |
| 2018 | $1,356 | 88 | AstraZeneca Pharmaceuticals LP ($201.03) |
| 2017 | $2,643 | 95 | PFIZER INC. ($674.83) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Inflammation | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Obesity | ||||||
| 06/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Diabetes Care | ||||||
| 05/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Oncology | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Respiratory | ||||||
| 12/05/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Gastroenterology | ||||||
| 10/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Gastroenterology | ||||||
| 10/02/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/28/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: VACCINES | ||||||
| 09/28/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: VACCINES | ||||||
| 09/20/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 6,469 | 8,567 | $650,293 | $157,723 |
| 2022 | 35 | 2,391 | 3,482 | $468,455 | $117,021 |
| 2021 | 36 | 3,717 | 5,218 | $769,659 | $201,109 |
| 2020 | 42 | 4,204 | 5,865 | $993,020 | $244,782 |
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 438 | $139,794 | $41,826 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $55,367 | $24,312 | 43.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 1,010 | 1,529 | $84,421 | $15,825 | 18.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 864 | 1,191 | $76,306 | $15,626 | 20.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 990 | 1,477 | $73,660 | $11,240 | 15.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 481 | 577 | $48,410 | $9,497 | 19.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 433 | 574 | $27,265 | $5,455 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 332 | 404 | $10,836 | $3,391 | 31.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 42 | 42 | $4,200 | $3,184 | 75.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 159 | 159 | $7,383 | $2,945 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 38 | $8,450 | $2,571 | 30.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 221 | 248 | $12,400 | $2,192 | 17.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 112 | 118 | $11,574 | $2,126 | 18.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 119 | 134 | $10,454 | $1,981 | 18.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 107 | 118 | $9,078 | $1,700 | 18.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 11 | 11 | $6,200 | $1,573 | 25.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 83 | 115 | $2,875 | $1,536 | 53.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $2,220 | $1,168 | 52.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 475 | 522 | $13,050 | $1,148 | 8.8% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 144 | 166 | $6,146 | $1,117 | 18.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 114 | 129 | $5,652 | $1,069 | 18.9% |
| 83550 | Iron binding capacity | Office | 2023 | 85 | 116 | $5,800 | $994.12 | 17.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 34 | 34 | $1,700 | $986.34 | 58.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 21 | 21 | $4,102 | $805.77 | 19.6% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 12 | 12 | $8,540 | $761.53 | 8.9% |
About Dr. Avishai Mendelson, MD
Dr. Avishai Mendelson, MD is a Internal Medicine healthcare provider based in Jupiter, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760476477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avishai Mendelson, MD has received a total of $9,798 in payments from pharmaceutical and medical device companies, with $321.15 received in 2024. These payments were reported across 519 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,526).
As a Medicare-enrolled provider, Mendelson has provided services to 16,781 Medicare beneficiaries, totaling 23,132 services with total Medicare billing of $720,635. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Jupiter, FL
- Active Since 09/08/2005
- Last Updated 10/27/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760476477
Products in Payments
- Ozempic (Drug) $891.27
- ENTRESTO (Drug) $656.65
- TRUMENBA (Biological) $600.25
- FARXIGA (Drug) $577.03
- ELIQUIS (Drug) $478.41
- Kerendia (Drug) $435.31
- JARDIANCE (Drug) $359.44
- TRULICITY (Drug) $316.04
- XIFAXAN (Drug) $239.68
- UBRELVY (Drug) $204.98
- CHANTIX (Drug) $202.13
- SYMBICORT (Drug) $201.96
- RYBELSUS (Drug) $200.45
- Rybelsus (Drug) $168.63
- Vascepa (Drug) $163.58
- BREZTRI (Drug) $150.27
- PREVNAR - 13 (Biological) $148.26
- Otezla (Drug) $139.58
- TOUJEO (Drug) $137.19
- Intracept (Device) $135.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jupiter
Dr. Naveen Reddy, Md, MD
Internal Medicine — Payments: $157,805
Hector Florentino
Internal Medicine — Payments: $27,870
Alexandra Berger, M.d, M.D
Internal Medicine — Payments: $11,580
Kevin Green, M.d, M.D
Internal Medicine — Payments: $11,076
Isabel Bueno, M.d, M.D
Internal Medicine — Payments: $9,448
Dr. Hemang Panchal, Md, MD
Internal Medicine — Payments: $8,422